SPY336.81+4.44 1.34%
DIA278.78+4.36 1.59%
IXIC11,254.20+168.95 1.52%

Vanda Pharmaceuticals' Interim Analysis From ODYSSEY Study Shows Tradipitant May Accelerate Clinical Improvement In Patients WIth COVID-19 Pneumonia

Benzinga · 08/18/2020 11:28